2026-08-12 Olomorasib Wins FDA Breakthrough Therapy Status Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer Read More 177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment Read More Videos Fixed-Duration Cevostamab Yields Durable Responses Off Therapy Watch Now Bringing Robotic Mastectomy to a Regional Health System Expands Access Watch Now Trending What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care? Read More Immunotherapy Plus iSBRT Boosts Response in PD-L1-Negative Breast Cancer Read More 回上一頁
